Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors

Mauro Di Matteo; Alessandra Ammazzalorso; Federico Andreoli; Irene Caffa; Barbara De Filippis; Marialuigia Fantacuzzi; Letizia Giampietro; Cristina Maccallini; Alessio Nencioni; Marco Parenti; Debora Soncini; Alberto Del Rio; Rosa Amoroso

doi:10.1016/j.bmcl.2016.04.078

Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors

Mauro Di Matteo, Alessandra Ammazzalorso, Federico Andreoli, Irene Caffa, Barbara De Filippis, Marialuigia Fantacuzzi, Letizia Giampietro, Cristina Maccallini, Alessio Nencioni, Marco Parenti, Debora Soncini, Alberto Del Rio, Rosa Amoroso

A.O.U. San Martino - IST, Istituto Nazionale Ricerca sul Cancro (GENOVA)

Research output: Contribution to journal › Article › peer-review

Abstract

The most frequently used treatment for hormone receptor positive breast cancer in post-menopausal women are aromatase inhibitors. In order to develop new aromatase inhibitors, we designed and synthesized new imidazolylmethylpiperidine sulfonamides using the structure of the previously identified aromatase inhibitor SYN 20028567 as starting lead. By this approach, three new aromatase inhibitors with IC₅₀ values that are similar to that of letrozole and SYN 20028567 were identified.

Original language	English
Journal	Bioorganic and Medicinal Chemistry Letters
DOIs	https://doi.org/10.1016/j.bmcl.2016.04.078
Publication status	Accepted/In press - Mar 17 2016

Keywords

Anticancer agents
Aromatase inhibitor
Imidazole
Sulfonamide
Synthesis

ASJC Scopus subject areas

Biochemistry
Clinical Biochemistry
Molecular Biology
Molecular Medicine
Organic Chemistry
Drug Discovery
Pharmaceutical Science

Access to Document

10.1016/j.bmcl.2016.04.078

Fingerprint Dive into the research topics of 'Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors'. Together they form a unique fingerprint.

Cite this

Di Matteo, M., Ammazzalorso, A., Andreoli, F., Caffa, I., De Filippis, B., Fantacuzzi, M., Giampietro, L., Maccallini, C., Nencioni, A., Parenti, M., Soncini, D., Del Rio, A., & Amoroso, R. (Accepted/In press). Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors. Bioorganic and Medicinal Chemistry Letters. https://doi.org/10.1016/j.bmcl.2016.04.078

Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors. / Di Matteo, Mauro; Ammazzalorso, Alessandra; Andreoli, Federico; Caffa, Irene; De Filippis, Barbara; Fantacuzzi, Marialuigia; Giampietro, Letizia; Maccallini, Cristina; Nencioni, Alessio; Parenti, Marco; Soncini, Debora; Del Rio, Alberto; Amoroso, Rosa.

In: Bioorganic and Medicinal Chemistry Letters, 17.03.2016.

Research output: Contribution to journal › Article › peer-review

Di Matteo, M, Ammazzalorso, A, Andreoli, F, Caffa, I, De Filippis, B, Fantacuzzi, M, Giampietro, L, Maccallini, C, Nencioni, A, Parenti, M, Soncini, D, Del Rio, A & Amoroso, R 2016, 'Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors', Bioorganic and Medicinal Chemistry Letters. https://doi.org/10.1016/j.bmcl.2016.04.078

Di Matteo, Mauro ; Ammazzalorso, Alessandra ; Andreoli, Federico ; Caffa, Irene ; De Filippis, Barbara ; Fantacuzzi, Marialuigia ; Giampietro, Letizia ; Maccallini, Cristina ; Nencioni, Alessio ; Parenti, Marco ; Soncini, Debora ; Del Rio, Alberto ; Amoroso, Rosa. / Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors. In: Bioorganic and Medicinal Chemistry Letters. 2016.

@article{556082dc36f74f95ab8ef89b4642318f,

title = "Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors",

abstract = "The most frequently used treatment for hormone receptor positive breast cancer in post-menopausal women are aromatase inhibitors. In order to develop new aromatase inhibitors, we designed and synthesized new imidazolylmethylpiperidine sulfonamides using the structure of the previously identified aromatase inhibitor SYN 20028567 as starting lead. By this approach, three new aromatase inhibitors with IC50 values that are similar to that of letrozole and SYN 20028567 were identified.",

keywords = "Anticancer agents, Aromatase inhibitor, Imidazole, Sulfonamide, Synthesis",

author = "{Di Matteo}, Mauro and Alessandra Ammazzalorso and Federico Andreoli and Irene Caffa and {De Filippis}, Barbara and Marialuigia Fantacuzzi and Letizia Giampietro and Cristina Maccallini and Alessio Nencioni and Marco Parenti and Debora Soncini and {Del Rio}, Alberto and Rosa Amoroso",

year = "2016",

month = mar,

day = "17",

doi = "10.1016/j.bmcl.2016.04.078",

language = "English",

journal = "Bioorganic and Medicinal Chemistry Letters",

issn = "0960-894X",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors

AU - Di Matteo, Mauro

AU - Ammazzalorso, Alessandra

AU - Andreoli, Federico

AU - Caffa, Irene

AU - De Filippis, Barbara

AU - Fantacuzzi, Marialuigia

AU - Giampietro, Letizia

AU - Maccallini, Cristina

AU - Nencioni, Alessio

AU - Parenti, Marco

AU - Soncini, Debora

AU - Del Rio, Alberto

AU - Amoroso, Rosa

PY - 2016/3/17

Y1 - 2016/3/17

N2 - The most frequently used treatment for hormone receptor positive breast cancer in post-menopausal women are aromatase inhibitors. In order to develop new aromatase inhibitors, we designed and synthesized new imidazolylmethylpiperidine sulfonamides using the structure of the previously identified aromatase inhibitor SYN 20028567 as starting lead. By this approach, three new aromatase inhibitors with IC50 values that are similar to that of letrozole and SYN 20028567 were identified.

AB - The most frequently used treatment for hormone receptor positive breast cancer in post-menopausal women are aromatase inhibitors. In order to develop new aromatase inhibitors, we designed and synthesized new imidazolylmethylpiperidine sulfonamides using the structure of the previously identified aromatase inhibitor SYN 20028567 as starting lead. By this approach, three new aromatase inhibitors with IC50 values that are similar to that of letrozole and SYN 20028567 were identified.

KW - Anticancer agents

KW - Aromatase inhibitor

KW - Imidazole

KW - Sulfonamide

KW - Synthesis

UR - http://www.scopus.com/inward/record.url?scp=84965020612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84965020612&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2016.04.078

DO - 10.1016/j.bmcl.2016.04.078

M3 - Article

AN - SCOPUS:84965020612

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

ER -